Alnylam Pharmaceuticals, Inc. vs Johnson & Johnson — Stock Comparison

ALNY
Alnylam Pharmaceuticals, Inc.
$296.11
▼ 4.32%
vs
JNJ
Johnson & Johnson
$227.19
▼ 1.16%
Q·Score Winner
Alnylam Pharmaceuticals, Inc.
ALNY8/10vs 7.1/10

Q·Score Breakdown

8
Bullish
Overall
7.1
Bullish
8.2
Quality
9.3
6.2
Health
6.5
8
Growth
5.1
9.7
Valuation
7.3
7.5
Sentiment
6.5
ALNY

Consensus analyst target of $449.48 is 52% above current price.

JNJ

High-quality business with 26% return on equity and 22% profit margins.

earnings contracting 53% year-over-year.

Analyst Consensus

BUY
Target $449.48 (+51.8%)
25 analysts
BUY
Target $252.42 (+11.1%)
24 analysts

Fundamentals

ALNY
JNJ
74.6×
Trailing P/E
26.3×
21.2×
Forward P/E
17.9×
12.6%
Profit Margin
21.8%
80.8%
Gross Margin
68.0%
90.4%
ROE
26.4%
96.4%
Revenue Growth
9.9%
Earnings Growth
-52.9%
0.38
Beta
0.33
Price / Book
$39.5B
Market Cap
$546.9B
$246 – $496
52-Week Range
$146 – $252

Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load. How it's calculated →